Our People

The team behind HARMONY.

A team built for this problem. A physicist who developed new equations for molecular behavior. An oncologist who publishes in Nature. A lawyer with deep experience in life science IP and company building. Different disciplines, one shared conviction: physics, not pattern matching, is how drug discovery moves forward.

Founding Team

Physics, medicine, and execution.

Chase K. McMichael

Founder · CEO · Chief Science Officer

Founder, CEO, and Chief Science Officer of InfiniGraph. Developed the ARC-X platform and THE ONE equation, a discovery that transforms chromatography into a platform for molecular separation. Created HARMONY as the culmination of decades of work across chemistry, materials science, and quantum-inspired physics. Inventor or co-inventor of 13 U.S. patents and published in numerous technical publications. 7 provisional patents and 210+ claims filed at InfiniGraph.

BS Physics & Chemistry 7 Provisional Patents 210+ Claims Filed 9 CoM Families

Lincoln D. Nadauld, MD, PhD

Chief Medical Officer

Practicing precision oncologist at Intermountain Health. First and senior author in Nature Genetics and Nature — two of the most prestigious scientific journals in the world. Translates genomic variant data into clinical strategy. Senior and corresponding author on InfiniGraph's DDR validation manuscript. Leads clinical development and target selection.

MD, PhD Nature Genetics Author Precision Oncologist Intermountain Health

Michael Wiley, JD

General Counsel

Co-founder of Guardant Health, one of the defining liquid biopsy companies in oncology — now a publicly traded company with a market cap exceeding $3 billion. Deep expertise in life science IP strategy, licensing, and commercialization. Oversees InfiniGraph's IP fortress architecture and pharma partnership structure.

JD Guardant Health Co-Founder $3B+ Public Company Life Science IP Expert

We didn't build a typical biotech team. We built the team this problem required.

InfiniGraph — 2026

Join the Mission

We are building the team that changes drug discovery.

If you are a scientist, engineer, or operator who believes physics-first drug discovery is the future of medicine, we want to hear from you.

Get in touch